Reta (GLP-1 / GLP-2 / GIP) (10mg)
Best Seller
Reta (GLP-1 / GLP-2 / GIP) (10mg)
14 left in stock
|
290 sold this week
-
Buy 5 for $171
save 10% -
Buy 9 for $152
save 20%
-
-
Description
Reta (10mg)
Multi-Receptor Peptide for Metabolic and Weight Management Research
Reta (10mg) is a novel research peptide designed for the investigation of advanced metabolic pathways and weight regulation mechanisms. As a triple-agonist targeting GLP-1, GIP, and glucagon receptors, Reta is a promising compound in preclinical research models focusing on energy balance, fat metabolism, and glucose homeostasis.
Product Overview
Each vial contains 10mg of high-purity lyophilized Reta, ideal for controlled studies examining its multi-pathway action. Researchers utilize this peptide to explore its potential effects on insulin sensitivity, lipid oxidation, and appetite regulation, contributing to the growing field of metabolic disorder treatment models.
Key Research Attributes:
- Triple-Receptor Agonism: Simultaneously activates GLP-1, GIP, and glucagon receptors, enabling research into synergistic effects on metabolism and weight modulation.
- Metabolic Disorder Applications: Frequently used in studies related to obesity, type 2 diabetes, and insulin resistance mechanisms.
- Energy Balance Modulation: Investigated for its ability to reduce food intake, enhance thermogenesis, and improve glycemic control in animal models.
- Laboratory-Grade Purity: Formulated for stability, accuracy, and consistency across experimental trials in metabolic and endocrinology labs.
Applications in Scientific Research
- GLP-1/GIP/glucagon receptor signaling studies
- Obesity and fat oxidation research models
- Preclinical evaluation of multi-targeted weight loss peptides
- Endocrine regulation and appetite hormone analysis
- Type 2 diabetes and insulin response studies
Format and Storage
Form: Lyophilized powder
Purity: >99%
Storage: Store at -20°C for optimal long-term stability
Reconstitution: Use bacteriostatic water for preparation in laboratory settings
Disclaimer: Reta (10mg) is supplied strictly for research and in vitro laboratory use. It is not intended for human or veterinary application. All usage must comply with institutional and regulatory guidelines.
Chemical Makeup
Molecular Formula
- Reta: C310H481N87O94
Molecular Weight
- Reta: 6959.5 g/mol
Sequence
- Reta: Full amino acid sequence proprietary to ongoing research; known for GLP-1/GIP/glucagon triple-agonist activity.
Other Known Titles
- Reta: LY3437943, Triple Agonist Peptide
Reta (10mg) is intended exclusively for research and scientific laboratory use. Please review our Terms and Conditions before ordering.
More Information
| Purity Percentage | 99% Purity |
|---|---|
| Volume | 10MG |
| Bought This Week | 290 |
| New | Yes |
| Sale | Yes |
Research
Reta: Effects, Benefits, and Side Effects
Reta is an investigational peptide that functions as a triple-receptor agonist, targeting GLP-1, GIP, and glucagon receptors. This multifaceted mechanism aims to enhance metabolic regulation, offering potential benefits in weight management and glycemic control. Below are ten reputable sources providing insights into Reta’s effects, benefits, and side effects.
-
“Reta: Uses, Side Effects, Availability and More”
Explores Reta’s mechanism of action, including appetite reduction, slowed digestion, and common GI side effects.
Read more -
“Reta Overview, Dosage, and Risks”
Covers dosing concepts, mechanism, and key safety considerations for this triple-agonist peptide.
Read more -
“Reta: Side Effects, Complications, and Risk Profile”
Examines gastrointestinal and cardiovascular side effects, plus risk management strategies from trial data.
Read more -
“What to Know About Reta Weight-Loss Drug”
Discusses Reta as a grey-market, experimental weight-loss drug and compares it with approved GLP-1/GIP agents.
Read more -
“What are the Side Effects of Reta?”
Outlines GI side effects including nausea, vomiting, diarrhea, and constipation, based on emerging clinical data.
Read more -
“Everything You Need to Know About Reta”
Comprehensive explanation of Reta’s triple-receptor targeting and effects on insulin, hunger, and metabolism.
Read more -
“Reta UK Explained: Benefits, Dosage, and Side Effects”
UK-focused overview of benefits, potential dose ranges, and typical side effects of this investigational drug.
Read more -
“Understanding Reta: A Novel Drug for Weight Loss”
Reviews trial outcomes where participants lost around a quarter of their body weight and summarises key safety findings.
Read more -
“Reta Dosage Calculator and Chart”
Provides a titration schedule and dosing chart based on current trial-style escalation protocols.
Read more -
“New Drug Reta Outshines Ozempic and Helps People Lose Quarter of Weight”
Summarises mid-stage trial data where the highest dose led to ~24% mean weight reduction versus placebo.
Read more
Certificate of Analysis
